Project Grant HT94252410445
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$861K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The Trustees of the University of Pennsylvania were awarded a $299,099 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Metabolic Target Identification in Age-Associated B Cells from May 1, 2023 through April 30, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health care through innovative medical research, this...
The University of Pennsylvania, through its Clinical Practices division, was awarded a $812,500 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "Targeting UGCG in the Melanoma Tumor Microenvironment." This 3-year research project, which commenced on September 1, 2024, aims to investigate innovative approaches to treating melanoma, a serious form of skin cancer, with a focus on modulating the tumor...
The University of Pennsylvania received a $2,060,500 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME". The award period is from September 1, 2023 to August 31, 2027. Through this Project Grant, the University of Pennsylvania will perform biomedical research to investigate innovative solutions for healthcare challenges facing U.S. service...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
The University of Pennsylvania has been awarded a $650,001.50 Cooperative Agreement from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports a clinical trial site application for the Kidney Cancer Research Consortium, with a performance period from September 15, 2024 to September 14, 2026. As a leading academic medical center, the University of Pennsylvania will leverage its extensive research capabilities and...
The University of Pennsylvania was awarded a $1,577,505 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from April 2025 to April 2029, supports the development of a next-generation mRNA-LNP therapy to allow gluten tolerance in celiac disease. The University of Pennsylvania, a leading academic medical center, will leverage its expertise in biomedical research...
This $1,199,997.00 Project Grant award from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), is funding research to prevent trauma-related infections during prolonged care. The grant was awarded on Sep 30, 2023 to The Trustees Of The University Of Pennsylvania - doing business as Clinical Practices Of The University Of Pennsylvania, a private university and non-profit research institution. The research aims to develop...
The University of Pennsylvania has been awarded a $2,027,311 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant will fund research focused on implementing suicide prevention strategies within the National Guard. The research project aims to transform healthcare for military service members by exploring innovative approaches to preventing and managing mental health conditions relevant to the military...
This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a...
The Trustees of the University of Pennsylvania received a $812,344 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on A Novel Inflammatory Mediator for Rheumatoid Arthritis from July 15, 2021 through July 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...